These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 676253)

  • 21. [Intravenous injection of isoniazid and PAS twice weekly to outpatients with tuberculosis in rural areas].
    Ursov IG; Volokitin FN; Borovinskaia TA
    Probl Tuberk; 1983 Nov; (11):42-5. PubMed ID: 6675002
    [No Abstract]   [Full Text] [Related]  

  • 22. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 23. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanism of excretion of HINA metabolites by the kidneys of patients with pulmonary tuberculosis].
    Dudckik GKh; Bilyk MA
    Probl Tuberk; 1975; (5):57-61. PubMed ID: 1144347
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoniazid inactivation status and the development of chronic tuberculosis.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(3):227-34. PubMed ID: 5195905
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
    Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M; Banaszkiewicz H; Czerwiński Z; Królikowska H; Krahowska M; Malecki S; Pezińska Z; Pilch Z; Przemyska B; Szustrowa I; Wardowa A
    Gruzlica; 1973 Jul; 41(7):755-64. PubMed ID: 4730976
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM; Durante C; Ceicu A; el Fassi el Fahri M; Bahsoun H
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of treatment by a combination of thiocarlide and isoniazid in previously untreated pulmonary tuberculosis].
    Aksüğür H; Gülbaran R; Cakirca R
    Poumon Coeur; 1967; 23(6):729-38. PubMed ID: 6070030
    [No Abstract]   [Full Text] [Related]  

  • 32. [Concentration in the blood and excretion of para-aminosalicylic acid and its metabolites after intake of BEPAS preparation].
    Savula MM
    Probl Tuberk; 1973; 51(10):44-7. PubMed ID: 4784037
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 34. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA
    Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111
    [No Abstract]   [Full Text] [Related]  

  • 35. [The function of the cardiovascular system in patients with pulmonary tuberculosis treated by intravenous administration of streptomycin, tubazid and PAS].
    Golanov VS
    Vrach Delo; 1969 Jun; 6():62-6. PubMed ID: 5821665
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of treatment of pulmonary tuberculosis under conditions of compulsory isolation].
    Zaworski C
    Gruzlica; 1967 May; 35(5):441-5. PubMed ID: 6056258
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ambulatory intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rudoĭ NM; Simonian LK
    Klin Med (Mosk); 1973 Jul; 51(7):89-92. PubMed ID: 4786268
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 39. [Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
    Hashimoto T; Shimao T; Aoki M; Misawa H; Takasawa N; Shiozawa S
    Kekkaku; 1984 Jun; 59(6):369-76. PubMed ID: 6492547
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.